167 related articles for article (PubMed ID: 8097704)
1. Identification of major metabolites of the catechol-O-methyltransferase inhibitor nitecapone in the rat and dog.
Wikberg T; Taskinen J
Drug Metab Dispos; 1993; 21(2):325-33. PubMed ID: 8097704
[TBL] [Abstract][Full Text] [Related]
2. Identification of major metabolites of the catechol-O-methyltransferase-inhibitor nitecapone in human urine.
Taskinen J; Wikberg T; Ottoila P; Kanner L; Lotta T; Pippuri A; Bäckström R
Drug Metab Dispos; 1991; 19(1):178-83. PubMed ID: 1673395
[TBL] [Abstract][Full Text] [Related]
3. Identification of major metabolites of the catechol-O-methyltransferase inhibitor entacapone in rats and humans.
Wikberg T; Vuorela A; Ottoila P; Taskinen J
Drug Metab Dispos; 1993; 21(1):81-92. PubMed ID: 8095232
[TBL] [Abstract][Full Text] [Related]
4. Metabolite profiles of two [14C]-labelled catechol O-methyltransferase inhibitors, nitecapone and entacapone, in rat and mouse urine and rat bile.
Wikberg T; Vuorela A
Eur J Drug Metab Pharmacokinet; 1994; 19(2):125-35. PubMed ID: 8001593
[TBL] [Abstract][Full Text] [Related]
5. Identification of major urinary metabolites of the catechol-O-methyltransferase inhibitor entacapone in the dog.
Wikberg T; Ottoila P; Taskinen J
Eur J Drug Metab Pharmacokinet; 1993; 18(4):359-67. PubMed ID: 8020535
[TBL] [Abstract][Full Text] [Related]
6. Determination of nitecapone and (13C6)nitecapone in human plasma by gas chromatography/mass spectrometry.
Ottoila P; Pakkala E; Karlsson C; Taskinen J
Biol Mass Spectrom; 1991 Dec; 20(12):771-6. PubMed ID: 1812986
[TBL] [Abstract][Full Text] [Related]
7. Enzyme-assisted synthesis and structural characterization of nitrocatechol glucuronides.
Luukkanen L; Kilpeläinen I; Kangas H; Ottoila P; Elovaara E; Taskinen J
Bioconjug Chem; 1999; 10(1):150-4. PubMed ID: 9893978
[TBL] [Abstract][Full Text] [Related]
8. Determination of a catechol-O-methyltransferase inhibitor, nitecapone, in human plasma and urine by liquid chromatography.
Wikberg T; Taskinen J
J Pharm Biomed Anal; 1991; 9(1):59-64. PubMed ID: 2043724
[TBL] [Abstract][Full Text] [Related]
9. Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens.
Garner CE; Burka LT; Etheridge AE; Matthews HB
Toxicol Appl Pharmacol; 2000 Jan; 162(2):115-23. PubMed ID: 10637135
[TBL] [Abstract][Full Text] [Related]
10. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs.
Prakash C; Cui D; Potchoiba MJ; Butler T
Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of phase I and phase II metabolic pathways of rhein: species differences and their potential relevance.
Dahms M; Lotz R; Lang W; Renner U; Bayer E; Spahn-Langguth H
Drug Metab Dispos; 1997 Apr; 25(4):442-52. PubMed ID: 9107544
[TBL] [Abstract][Full Text] [Related]
12. Identification of ibopamine metabolites in rat and dog urine.
Kuo GY; Hwang BY; Lynn RK
Drug Metab Dispos; 1988; 16(6):793-8. PubMed ID: 2907455
[TBL] [Abstract][Full Text] [Related]
13. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
[TBL] [Abstract][Full Text] [Related]
15. Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase.
Yao J; Li Y; Chang M; Wu H; Yang X; Goodman JE; Liu X; Liu H; Mesecar AD; Van Breemen RB; Yager JD; Bolton JL
Chem Res Toxicol; 2003 May; 16(5):668-75. PubMed ID: 12755597
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
[TBL] [Abstract][Full Text] [Related]
17. Identification of phase-I and phase-II metabolites of fluphenazine in rat bile. Intact glucuronide and sulfate conjugates.
Jackson CJ; Hubbard JW; McKay G; Cooper JK; Hawes EM; Midha KK
Drug Metab Dispos; 1991; 19(1):188-93. PubMed ID: 1673397
[TBL] [Abstract][Full Text] [Related]
18. Directly coupled liquid chromatography with inductively coupled plasma mass spectrometry and orthogonal acceleration time-of-flight mass spectrometry for the identification of drug metabolites in urine: application to diclofenac using chlorine and sulfur detection.
Corcoran O; Nicholson JK; Lenz EM; Abou-Shakra F; Castro-Perez J; Sage AB; Wilson ID
Rapid Commun Mass Spectrom; 2000; 14(24):2377-84. PubMed ID: 11114054
[TBL] [Abstract][Full Text] [Related]
19. Identification of the main urinary metabolites of omeprazole after an oral dose to rats and dogs.
Hoffmann KJ
Drug Metab Dispos; 1986; 14(3):341-8. PubMed ID: 2872036
[TBL] [Abstract][Full Text] [Related]
20. Identification of major sulfate conjugates in the metabolism of propranolol in dog and man.
Walle T; Walle UK; Knapp DR; Conradi EC; Bargar EM
Drug Metab Dispos; 1983; 11(4):344-9. PubMed ID: 6137341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
